Spontaneous Transfer of Indocyanine Green from Liposomes to Albumin Is Inhibited by the Antioxidant α-Tocopherol
Source abstract
Abstract
Indocyanine Green (ICG) is a clinically approved organic dye with near-infrared absorption and fluorescence. Over the years, many efforts to improve the photophysical and pharmacokinetic properties of ICG have investigated numerous nanoparticle formulations, especially liposomes with membrane-embedded ICG. A series of systematic absorption and fluorescence experiments, including FRET experiments using ICG as a fluorescence energy acceptor, found that ICG transfers spontaneously from liposomes to albumin protein residing in the external solution with a half-life of ∼10 min at 37 °C. Moreover, transfer of ICG from liposome membranes to external albumin reduces light-activated leakage from thermosensitive liposomes with membrane-embedded ICG. A survey of lipophilic liposome additives discovered that the presence of clinically approved antioxidant, α-tocopherol, greatly increases ICG retention in the liposomes (presumably by forming favorable aromatic stacking interactions), inhibits ICG photobleaching and prevents albumin-induced reduction of light-triggered liposome leakage. This new insight will help researchers with the specific task of optimizing ICG-containing liposomes for fluorescence imaging or phototherapeutics. More broadly, the results suggest a broader design concept concerning light triggered liposome leakage, that is, proximity of the light absorbing dye to the bilayer membrane is a critical design feature that impacts the extent of liposome leakage.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Gold and Silver Nanoparticles Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry and Biochemistry, 251 Nieuwland Science Hall, University of Notre Dame, Notre Dame Indiana 46556, United States
Funding
National Institute of General Medical Sciences
References (96)
Show source-provided references
1. 10.1097/MD.000000000001476510.1097/MD.0000000000014765 ↗
2. 10.3171/2020.10.FOCUS2078210.3171/2020.10.FOCUS20782 ↗
3. 10.3748/wjg.v27.i38.637410.3748/wjg.v27.i38.6374 ↗
4. 10.1177/155335061560405310.1177/1553350615604053 ↗
5. 10.1152/japplphysiol.01269.200910.1152/japplphysiol.01269.2009 ↗
6. 10.1002/cptc.20210004510.1002/cptc.202100045 ↗
7. 10.1016/j.pdpdt.2018.10.01110.1016/j.pdpdt.2018.10.011 ↗
8. 10.3389/fonc.2021.63832710.3389/fonc.2021.638327 ↗
9. 10.1021/bc400050k10.1021/bc400050k ↗
10. 10.1016/j.biotechadv.2016.04.00110.1016/j.biotechadv.2016.04.001 ↗
11. 10.1039/D1NA00059D10.1039/D1NA00059D ↗
12. 10.3389/fchem.2020.0053510.3389/fchem.2020.00535 ↗
13. 10.1117/1.JBO.22.9.09600710.1117/1.JBO.22.9.096007 ↗
14. 10.1021/bi500021j10.1021/bi500021j ↗
15. 10.2147/IJN.S15547510.2147/IJN.S155475 ↗
16. 10.1021/acs.molpharmaceut.6b0020710.1021/acs.molpharmaceut.6b00207 ↗
17. 10.3390/pharmaceutics1208076310.3390/pharmaceutics12080763 ↗
18. 10.1016/j.jconrel.2018.06.02910.1016/j.jconrel.2018.06.029 ↗
19. 10.2217/nnm-2019-023310.2217/nnm-2019-0233 ↗
20. 10.1016/j.carbpol.2019.11514310.1016/j.carbpol.2019.115143 ↗
21. 10.1016/j.nano.2011.01.00110.1016/j.nano.2011.01.001 ↗
22. 10.3390/pharmaceutics1303030510.3390/pharmaceutics13030305 ↗
23. 10.1016/j.nano.2015.02.01910.1016/j.nano.2015.02.019 ↗
24. 10.1021/acsami.7b1599610.1021/acsami.7b15996 ↗
25. 10.1111/cbdd.1365210.1111/cbdd.13652 ↗
26. 10.1016/j.nano.2020.10226910.1016/j.nano.2020.102269 ↗
27. 10.1039/C9BM00551J10.1039/C9BM00551J ↗
28. 10.1016/j.pdpdt.2014.02.00110.1016/j.pdpdt.2014.02.001 ↗
29. 10.1016/j.pacs.2020.10021010.1016/j.pacs.2020.100210 ↗
30. 10.1186/s40425-019-0702-110.1186/s40425-019-0702-1 ↗
31. 10.1158/0008-5472.CAN-10-027110.1158/0008-5472.CAN-10-0271 ↗
32. 10.1021/acs.langmuir.6b0071610.1021/acs.langmuir.6b00716 ↗
33. 10.3390/ijms2213691410.3390/ijms22136914 ↗
34. 10.1016/j.biomaterials.2014.10.01410.1016/j.biomaterials.2014.10.014 ↗
35. 10.1021/acs.molpharmaceut.1c0098510.1021/acs.molpharmaceut.1c00985 ↗
36. 10.1039/C4RA09735A10.1039/C4RA09735A ↗
37. 10.1002/jbm.b.3423010.1002/jbm.b.34230 ↗
38. 10.3389/fphys.2014.0029910.3389/fphys.2014.00299 ↗
39. 10.1021/bi200096610.1021/bi2000966 ↗
40. 10.1002/anie.20110245910.1002/anie.201102459 ↗
41. 10.1529/biophysj.107.11160910.1529/biophysj.107.111609 ↗
42. 10.1016/j.rechem.2020.10009210.1016/j.rechem.2020.100092 ↗
43. 10.3389/fphys.2011.0008210.3389/fphys.2011.00082 ↗
44. 10.3390/bios1112050510.3390/bios11120505 ↗
45. 10.1016/j.addr.2019.04.00910.1016/j.addr.2019.04.009 ↗
46. 10.1021/mp500329z10.1021/mp500329z ↗
47. 10.1016/j.jconrel.2016.06.02710.1016/j.jconrel.2016.06.027 ↗
48. 10.1007/s11095-010-0190-y10.1007/s11095-010-0190-y ↗
49. 10.1016/j.colsurfb.2018.07.02210.1016/j.colsurfb.2018.07.022 ↗
50. 10.7150/thno.2222610.7150/thno.22226 ↗
51. 10.2494/photopolymer.32.11510.2494/photopolymer.32.115 ↗
52. 10.1016/j.nantod.2017.12.00610.1016/j.nantod.2017.12.006 ↗
53. 10.7150/ntno.4173710.7150/ntno.41737 ↗
54. 10.1016/j.mtcomm.2022.10320710.1016/j.mtcomm.2022.103207 ↗
55. Gleue L. · Cell · 2020 · 9 · 110.4236/cellbio.2020.91001 ↗
56. 10.1002/cyto.a.2285310.1002/cyto.a.22853 ↗
57. 10.1016/j.ejpb.2015.03.01910.1016/j.ejpb.2015.03.019 ↗
58. Close inspection of the bar graph in Figure 4 reveals some finer details concerning ICG transfer to BSA. For example, the presence of cholesterol slightly helps to retain ICG (compare composition1with no cholesterol and composition5with 40% cholesterol) but α-tocopherol is much better than cholesterol at retaining ICG (compare composition5with 40% cholesterol and composition7with 20% α-tocopherol). Indeed, cholesterol seems to attenuate the capability of α-tocopherol to retain ICG (compare composition7with 20% α-tocopherol and composition8with 20% cholesterol and 20% α-tocopherol) suggesting that cholesterol weakens the stabilizing aromatic stacking interactions between ICG and α-tocopherol.
59. 10.1006/abio.2001.522510.1006/abio.2001.5225 ↗
60. 10.1016/j.freeradbiomed.2021.09.01510.1016/j.freeradbiomed.2021.09.015 ↗
61. 10.1021/acs.jpcb.8b0906410.1021/acs.jpcb.8b09064 ↗
62. 10.1007/s00249-021-01548-y10.1007/s00249-021-01548-y ↗
63. 10.1039/C6CP08872D10.1039/C6CP08872D ↗
64. 10.1039/C3MB70373H10.1039/C3MB70373H ↗
65. 10.1002/biof.107010.1002/biof.1070 ↗
66. Ando T. · 1973 · 86
67. 10.1002/mnfr.20090043910.1002/mnfr.200900439 ↗
68. 10.1021/acs.jpcb.8b0501610.1021/acs.jpcb.8b05016 ↗
69. 10.1016/j.chemphyslip.2020.10491010.1016/j.chemphyslip.2020.104910 ↗
70. 10.1021/acscentsci.0c0000510.1021/acscentsci.0c00005 ↗
71. 10.1128/mBio.01017-1910.1128/mBio.01017-19 ↗
72. 10.1080/14756366.2021.188039710.1080/14756366.2021.1880397 ↗
73. 10.1002/macp.20140034210.1002/macp.201400342 ↗
74. 10.1016/j.bpj.2015.08.03210.1016/j.bpj.2015.08.032 ↗
75. 10.1093/jxb/erl00210.1093/jxb/erl002 ↗
76. 10.1111/tpj.1399310.1111/tpj.13993 ↗
77. 10.1111/pce.1216110.1111/pce.12161 ↗
78. 10.1002/biof.552007010610.1002/biof.5520070106 ↗
79. 10.1021/acs.jafc.6b0432910.1021/acs.jafc.6b04329 ↗
80. 10.1002/chem.20210281610.1002/chem.202102816 ↗
81. 10.1038/s41598-017-14401-010.1038/s41598-017-14401-0 ↗
82. 10.1515/nanoph-2021-019110.1515/nanoph-2021-0191 ↗
83. 10.1007/s11095-014-1560-710.1007/s11095-014-1560-7 ↗
84. 10.1039/C9BM02010A10.1039/C9BM02010A ↗
85. 10.1073/pnas.151879111210.1073/pnas.1518791112 ↗
86. 10.1155/2011/15247410.1155/2011/152474 ↗
87. 10.1038/s41467-021-25452-310.1038/s41467-021-25452-3 ↗
88. 10.1021/acsomega.1c0263210.1021/acsomega.1c02632 ↗
89. 10.1021/acsami.9b1451910.1021/acsami.9b14519 ↗
90. 10.1021/acsabm.1c0107010.1021/acsabm.1c01070 ↗
91. 10.1007/s40820-017-0166-010.1007/s40820-017-0166-0 ↗
92. 10.1088/2050-6120/ab736510.1088/2050-6120/ab7365 ↗
93. 10.1016/j.addr.2012.02.00610.1016/j.addr.2012.02.006 ↗
94. 10.3390/polym1407128610.3390/polym14071286 ↗
95. Mu J. · Angew. Chem., Int. Ed. · 2022 · 61 · e20211472210.1002/anie.202114722 ↗
96. 10.1021/jacs.9b1004310.1021/jacs.9b10043 ↗